DrugCore and RegulatoryCore are now live in the API and MCP. Read more

Amass
MCP showcasesSubmission evidence assembler

MCP Showcase

Submission evidence assembler

Name one drug asset; get a citation-auditable, Module-2.5-style evidence narrative — every pivotal Phase-3 trial, its describing papers, and a canonical Amass-ID audit trail — assembled from Amass's publication↔trial graph with trust metadata on every cited paper.

Download skillSee the prompt

New to Amass? Connect Amass to Claude first

6Phase-3 trials
37linked papers
0retracted
You getxlsxdocx2 files
Skillregulatoryclaude

The prompt

Paste this into Claude

Asset (drug)mavacamten
prompt
Use the submission-evidence-assembler skill.

Asset (drug): mavacamten

Why not just ask the model?

Ask a plain model to "assemble the published evidence base for mavacamten's HCM submission" and it invents the asset→trial→paper linkage — plausible trial acronyms, PMIDs, journals, and citation counts that read like the literature and are wrong.

  • Plain model: fabricated trial acronyms, made-up NCTs and PMIDs, guessed citation counts, and no way to tell a retracted paper from a sound one.
  • Amass: the real TrialCore rows for the asset's Phase-3 search, and each trial's referencesBiomedCore edge walked in one hop to the publications that describe it — every paper arriving with its PMID, journal, journalQualityJufo tier, isRetracted flag, and citation count copied verbatim. The cross-core edge is the load-bearing primitive; the canonical Amass IDs (AMTC_… / AMBC_…) are the stable audit trail.

Why a skill, not a prompt?

This is a multi-step orchestration, not a single question: one TrialCore search for the asset's pivotal trials, a 10-cap completeness check on that result set, a get_amass_trialcore_record per trial to read its identity and referencesBiomedCore array, then a fan-out — a get_amass_biomedcore_record for every referenced paper (37 fetches here) — followed by a union/dedupe across trials and a two-file Office assembly. Packaging it as a skill means you trigger the whole chain with one line instead of pasting a brittle, branch-heavy procedure every time.

Honest scope

It assembles and trust-screens evidence; it does not author regulatory conclusions. The Phase-3 search returns at most 10 trials — for mavacamten it returned 6, so the trial set is complete and the skill says so; an asset that hits the 10-cap is a relevance sample, not a census, and the skill fires a truncation banner (broaden by widening phase or wording and unioning the results). Per-paper figures are verbatim Amass fields and can lag the registry by hours; any abstract-derived claim the returned text does not state is written "not in abstract," never guessed. The verdict "0 of 37 cited papers carry isRetracted=true" is a checkable field claim, not an assurance of quality.

Install the skill

Add the skill to Claude

Download SKILL.md and add it to Claude (Settings → Capabilities → Skills, or drop it in your Claude Code skills directory), then paste the prompt above to trigger it.

More showcases

Keep exploring

csv+1
7linked papers
ranktitlejournalpublicationDate
1Efficacy and Safety of NVX-CoV2373 in Adults in the United States and MexicoThe New England journal of medicine2022-02-10
2Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical TrialJAMA network open2023-04-03
3Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 TrialmedRxiv (preprint)2022-09-21
clinical-evidenceSkill

Trial evidence trace

Paste one clinical-trial ID; get the exact published papers that describe it — pulled from Amass's publication↔trial graph, with trust metadata and abstract-grounded relevance notes.

docx
5Phase-3 trials

1. Pivotal Phase-3 program

AMASS EVIDENCE BRIEF

regulatoryPrompt

Tirzepatide evidence brief

Name a drug asset; get a citation-auditable Word evidence brief — pivotal Phase-3 trials, grounded efficacy and safety findings, and the trial↔paper links — every figure verbatim from Amass.

pdf
2MAESTRO trials
Resmetirom evidence snapshot — page 1
researchPrompt

Resmetirom evidence snapshot

Name a drug asset; get a one-page PDF evidence snapshot — regulatory status, pivotal trials, grounded efficacy figures and the trial↔paper link — every number verbatim from Amass.

Run it yourself

Connect Amass to Claude and paste the prompt.

No build, no deploy — the connector takes about a minute, then this workflow runs on your own inputs.

Connect Amass to ClaudeBrowse all showcases